Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC distributes funds

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission begins mailing 140,000 refund checks worth a total of $6 million to consumers who bought For Women Only supplements from QVC. The money comes from a 2009 settlement that resolved allegations the home shopping channel falsely advertised the supplement as a way to lose weight while still eating fatty, high-carb foods. QVC also must pay a $1.5 million civil penalty (1"The Tan Sheet" March 29, 2004)

You may also be interested in...



FTC goes after QVC

The home shopping channel violated a previous final order prohibiting QVC from using deceptive advertising practices to market weight-loss products, the FTC alleges in a March 24 complaint filed in Eastern Pennsylvania federal court. The commission maintains each airing of programs for Bee-Alive, For Women Only, Lipofactor Cellulite Target Lotion and Lite Bites a violation of the previous order. Programs touted testimonials from patients with cancer, lupus and multiple sclerosis who also claimed to have lost between 30 lbs and 140 lbs. In a same-day 1release, FTC points out the "claims for these products are not only unsubstantiated, but for some, scientifically impossible." Agency seeks monetary civil penalties, consumers redress and to permanently enjoin the Comcast subsidiary from violating the June 2000 order...

All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption

ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.

Will Switzerland’s Only EU Notified Body Survive Swixit Threat?

What will the fall-out of political tensions between the EU and Switzerland mean for notified bodies based in Switzerland, and for the future recognition of CE marks granted in one of the most important medtech markets in Europe?

Topics

UsernamePublicRestriction

Register

PS104065

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel